Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Kilpatrick Townsend hires DC chemistry and life sciences team

Kilpatrick Townsend & Stockton has added a chemistry and life sciences team to its Washington, DC office, joining from boutique intellectual property law firm Roberts Mlotkowski Safran & Cole

kilpatrick-dc-chemistry-teamnew.jpg

The team comprises partners Justin Krieger, Keith Fredlake and Jeffrey Gendzwill, along with counsel Rodney Rothwell and associates Nicoletta Kennedy and Troy Petersen.

Krieger (top right) is a registered patent attorney who focuses his practice on client counseling, district court and patent office litigation, and patent prosecution, with a technical expertise in chemistry, chemical engineering, medical devices, nanotechnology, mechanical engineering, and consumer products.


Fredlake (middle right) is a registered patent attorney who focuses his practice on intellectual property matters, including drafting and prosecuting patent applications, primarily in the chemical and life sciences industry.

Gendzwill (bottom right) is a registered patent attorney who concentrates his practice on patent-related matters with a focus on client counseling, portfolio strategy and management, domestic and foreign patent preparation and prosecution, and enforcement primarily in the chemical and life sciences industry.

more from across site and ros bottom lb

More from across our site

IP counsel urge the government to restrict safe harbour exceptions available to intermediaries and clear up doubts with the existing law
A New York lawyer could face sanctions after citing fake judgments generated by ChatGPT, but that doesn’t mean practitioners should shy away from AI
Klaus Grabinski told delegates at a UPC inauguration event that the proposed SEP regulation would limit access to justice
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar shares her thoughts on this year’s annual meeting in Singapore, where debates ranged from AI opportunities to improving law firm culture
The court’s ruling is a good reminder that US parties aren’t guaranteed attorney fees just because they win, say sources
With business confidence in a shaky state, Rachel Tan and Lisa Yong of Rouse discuss how in-house IP teams can manage their trademark portfolios through uncertain times
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
The US Supreme Court’s ruling wasn’t a surprise and reflects a trend that had already been bubbling away for a while, say tech and pharma counsel